Metabolic memory underlying minimal residual disease in breast cancer
Abstract Tumor relapse from treatment‐resistant cells (minimal residual disease, MRD) underlies most breast cancer‐related deaths. Yet, the molecular characteristics defining their malignancy have largely remained elusive. Here, we integrated multi‐omics data from a tractable organoid system with a...
Saved in:
Main Authors: | Ksenija Radic Shechter, Eleni Kafkia, Katharina Zirngibl, Sylwia Gawrzak, Ashna Alladin, Daniel Machado, Christian Lüchtenborg, Daniel C Sévin, Britta Brügger, Kiran R Patil, Martin Jechlinger |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c0276c0d71bf4b688df33f54bc4ee1f4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methodologies for Generating Brain Organoids to Model Viral Pathogenesis in the CNS
by: Hannah K. Hopkins, et al.
Published: (2021) -
Mutación del gen BRAF en pacientes con cánceres de colon y recto con KRAS no mutado
by: Roa,Iván, et al.
Published: (2014) -
Current Status of Breast Organoid Models
by: Srivarshini Cherukupalli Mohan, et al.
Published: (2021) -
Oncogene
Published: (1987) -
Human kidney organoids model the tacrolimus nephrotoxicity and elucidate the role of autophagy
by: Jin Won Kim, et al.
Published: (2021)